Vše

Co hledáte?

Vše
Projekty
Výsledky výzkumu
Subjekty

Rychlé hledání

  • Projekty podpořené TA ČR
  • Významné projekty
  • Projekty s nejvyšší státní podporou
  • Aktuálně běžící projekty

Chytré vyhledávání

  • Takto najdu konkrétní +slovo
  • Takto z výsledků -slovo zcela vynechám
  • “Takto můžu najít celou frázi”

Investigation of ochratoxin A and citrinin occurrence in medicinal herbal products from the Czech market

Identifikátory výsledku

  • Kód výsledku v IS VaVaI

    <a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F75010330%3A_____%2F25%3A00015134" target="_blank" >RIV/75010330:_____/25:00015134 - isvavai.cz</a>

  • Nalezeny alternativní kódy

    RIV/62690094:18470/25:50022420

  • Výsledek na webu

    <a href="https://link.springer.com/content/pdf/10.1007/s40264-025-01570-5.pdf?utm_source=clarivate&getft_integrator=clarivate" target="_blank" >https://link.springer.com/content/pdf/10.1007/s40264-025-01570-5.pdf?utm_source=clarivate&getft_integrator=clarivate</a>

  • DOI - Digital Object Identifier

    <a href="http://dx.doi.org/10.1007/s40264-025-01570-5" target="_blank" >10.1007/s40264-025-01570-5</a>

Alternativní jazyky

  • Jazyk výsledku

    angličtina

  • Název v původním jazyce

    Investigation of ochratoxin A and citrinin occurrence in medicinal herbal products from the Czech market

  • Popis výsledku v původním jazyce

    IntroductionMedicinal plants are extensively utilized as dietary supplements to encourage disease prevention and to support the treatment of various health disorders. Unfortunately, several plants are known for mycotoxin contamination, which may overwhelm any beneficial effects the plants might have.ObjectiveThe purpose of the study was to determine the presence of ochratoxin A (OTA) and citrinin (CIT) in medicinal herbal products (MHP).MethodsSixty samples of different MHP types were purchased on the Czech market during 2020-2021. Both mycotoxins were determined using high-performance liquid chromatography with a fluorescence detector with immunoaffinity columns employed as a pretreatment.ResultsIn total, 40% and 27% of samples were above the limit of quantification with the concentrations ranging up to 826.62 ng/g and 472.79 ng/g for OTA and CIT, respectively. The co-occurrence was confirmed in six MHP types.ConclusionsMHP could be a significant source of OTA and CIT. To protect the health of MHP users, it is desirable to continue monitoring the presence of mycotoxins in MHP. During this study, new OTA regulations for herbs came into force in the EU.

  • Název v anglickém jazyce

    Investigation of ochratoxin A and citrinin occurrence in medicinal herbal products from the Czech market

  • Popis výsledku anglicky

    IntroductionMedicinal plants are extensively utilized as dietary supplements to encourage disease prevention and to support the treatment of various health disorders. Unfortunately, several plants are known for mycotoxin contamination, which may overwhelm any beneficial effects the plants might have.ObjectiveThe purpose of the study was to determine the presence of ochratoxin A (OTA) and citrinin (CIT) in medicinal herbal products (MHP).MethodsSixty samples of different MHP types were purchased on the Czech market during 2020-2021. Both mycotoxins were determined using high-performance liquid chromatography with a fluorescence detector with immunoaffinity columns employed as a pretreatment.ResultsIn total, 40% and 27% of samples were above the limit of quantification with the concentrations ranging up to 826.62 ng/g and 472.79 ng/g for OTA and CIT, respectively. The co-occurrence was confirmed in six MHP types.ConclusionsMHP could be a significant source of OTA and CIT. To protect the health of MHP users, it is desirable to continue monitoring the presence of mycotoxins in MHP. During this study, new OTA regulations for herbs came into force in the EU.

Klasifikace

  • Druh

    J<sub>imp</sub> - Článek v periodiku v databázi Web of Science

  • CEP obor

  • OECD FORD obor

    30304 - Public and environmental health

Návaznosti výsledku

  • Projekt

  • Návaznosti

    I - Institucionalni podpora na dlouhodoby koncepcni rozvoj vyzkumne organizace

Ostatní

  • Rok uplatnění

    2025

  • Kód důvěrnosti údajů

    S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Údaje specifické pro druh výsledku

  • Název periodika

    Drug Safety

  • ISSN

    0114-5916

  • e-ISSN

    1179-1942

  • Svazek periodika

    48

  • Číslo periodika v rámci svazku

    11

  • Stát vydavatele periodika

    NZ - Nový Zéland

  • Počet stran výsledku

    13

  • Strana od-do

    1215-1227

  • Kód UT WoS článku

    001506913300001

  • EID výsledku v databázi Scopus

    2-s2.0-105007881796